Report - A phase 1 dose escalation study of continuous intravenous ... · HbS/β+-thalassemia, HbSC) 5.2.2 Patients with sickle cell disease aged 6 to 50 years old 5.2.3 Presence of sickle

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form